Skip to Main Content

Author Details

St??phanie Bibert
University Hospital and University of Lausanne
2001
46
27
PMIDPaper TitleJournal TitlePublished Year
36327219Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.PLoS Genet2022
30969488[Customised infectiology - Immunogenetics].Rev Med Suisse2019
31869396Herpes simplex encephalitis in adult patients with MASP-2 deficiency.PLoS Pathog2019
31225812IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients.AIDS2019
30234607Interferon lambda 3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma.AIDS2018
29046669Susceptibility to <i>Mycobacterium ulcerans</i> Disease (Buruli ulcer) Is Associated with <i>IFNG</i> and <i>iNOS</i> Gene Polymorphisms.Front Microbiol2017
28261910A systematic review and meta-analysis of HCV clearance.Liver Int2017
26924055Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation.Kidney Int2016
27788139Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations.PLoS One2016
25398456IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation.J Infect Dis2015
26261206Reply to Cunha et al.Clin Infect Dis2015
26118470Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.Nat Commun2015
25977268PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant.Clin Infect Dis2015
25301956Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation.J Infect Dis2015
24308755The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection.Aliment Pharmacol Ther2014
25534433Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.Nat Commun2014
25259701The IFNL3/4 οG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients.AIDS2014
23231085IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4.J Viral Hepat2013
23665287Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma.J Hepatol2013
23712427IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.J Exp Med2013
23734184Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development.PLoS One2013
22180014IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes.Hepatology2012
22808108A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C.PLoS One2012
22841784Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.Gastroenterology2012
22676361The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin.J Viral Hepat2012
22345656IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5.Gut2012
22095909Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.Hepatology2012
20723035The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C.J Viral Hepat2011
21390311Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms.PLoS One2011
21354446IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C.J Hepatol2011
21443535IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C.Aliment Pharmacol Ther2011
21454534FXYD proteins reverse inhibition of the Na+-K+ pump mediated by glutathionylation of its beta1 subunit.J Biol Chem2011
21147186Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.J Hepatol2011
21111740Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.Gastroenterology2011
19109419A link between FXYD3 (Mat-8)-mediated Na,K-ATPase regulation and differentiation of Caco-2 intestinal epithelial cells.Mol Biol Cell2009
19587147Mouse GLUT9: evidences for a urate uniporter.Am J Physiol Renal Physiol2009
19542013Reversible oxidative modification: a key mechanism of Na+-K+ pump regulation.Circ Res2009
17991751Phosphorylation of phospholemman (FXYD1) by protein kinases A and C modulates distinct Na,K-ATPase isozymes.J Biol Chem2008
18343874Establishment of cell-cell junctions depends on the oligomeric states of VE-cadherin.J Biochem2008
17592128Evolution of Na,K-ATPase beta m-subunit into a coregulator of transcription in placental mammals.Proc Natl Acad Sci U S A2007
17606467A novel family of transmembrane proteins interacting with beta subunits of the Na,K-ATPase.Hum Mol Genet2007
16828040[FXYD proteins: novel regulators of Na,K-ATPase].Med Sci (Paris)2006
17077088Structural and functional properties of two human FXYD3 (Mat-8) isoforms.J Biol Chem2006
12584200Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration.J Biol Chem2003
11821414Synergy between extracellular modules of vascular endothelial cadherin promotes homotypic hexameric interactions.J Biol Chem2002
11069895Self-assembly of the vascular endothelial cadherin ectodomain in a Ca2+-dependent hexameric structure.J Biol Chem2001
  • 1 - 46 of 46

Recommended Authors

Glenn Oliveira
Faculdade de Medicina
Career Start Year 2013
Number of shared co-authors 0
Vinod Kumar
The University of Queensland
Career Start Year 2008
Number of shared co-authors 8
Daizhan Zhou
The Fourth Affiliated Hospital, Zhejiang University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Andre Franke
Institute of Clinical Molecular Biology, Kiel University
Career Start Year 2005
Number of shared co-authors 19
Wanxia Li Tsai
National Institute of Arthritis
Career Start Year 2005
Number of shared co-authors 0
Tommaso Mazza
Fondazione IRCCS Casa Sollievo della Sofferenza,71013
Career Start Year 2005
Number of shared co-authors 0
Agnes C Paquet
Universite Cote d'Azur, CNRS UMR5
Career Start Year 2004
Number of shared co-authors 0
Thomas J Urban
Eshelman School of Pharmacy, University of North Carolina
Career Start Year 2003
Number of shared co-authors 3
Yi-Ting Wang
McGill Research Centre for Studies in Aging
Career Start Year 2003
Number of shared co-authors 0
Travis R Taylor
University of Toledo
Career Start Year 2002
Number of shared co-authors 0
Hua Ling
Chongqing Center for Disease Control and Prevention.
Career Start Year 2002
Number of shared co-authors 2
Sophia Derdak
Medical University of Vienna
Career Start Year 2001
Number of shared co-authors 2
Hsinyi Tsang
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2000
Number of shared co-authors 0
David K Crossman
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 1
Chao Xing
University of Texas Southwestern Medical Center
Career Start Year 1999
Number of shared co-authors 2
Priya Duggal
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1998
Number of shared co-authors 2
Fahd Al-Mulla
Dasman Diabetes Institute
Career Start Year 1998
Number of shared co-authors 3
Unnur Thorsteinsdottir
University of Iceland
Career Start Year 1995
Number of shared co-authors 23
Jacob Odeberg
The Arctic University of Norway
Career Start Year 1995
Number of shared co-authors 0
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 1
Andrea Hofmann
Institute of Human Genetics, University of Bonn and Department of Genomics
Career Start Year 1991
Number of shared co-authors 1
Chava Kimchi-Sarfaty
Center for Biologics Evaluation and Research
Career Start Year 1991
Number of shared co-authors 0
Thong T Nguyen
Gladstone Institute of Virology
Career Start Year 1991
Number of shared co-authors 0
Jong-Il Kim
Genomic Medicine Institute, Medical Research Center, Seoul National University
Career Start Year 1989
Number of shared co-authors 1
Sanja Glisic
Vinca Institute of Nuclear Sciences, The University of Belgrade
Career Start Year 1988
Number of shared co-authors 0
Philip J R Day
University of Cape Town
Career Start Year 1988
Number of shared co-authors 0
Jyoti Srivastava
Moffitt Cancer Center
Career Start Year 1986
Number of shared co-authors 0
Ludwig Wagner
Child and Family Research Institute, University of British Columbia
Career Start Year 1979
Number of shared co-authors 0
Stephen Kwok-Wing Tsui
The Chinese University of Hong Kong
Career Start Year 1979
Number of shared co-authors 0
Peter J Munson
and Blood Institute, National Institutes of Health
Career Start Year 1978
Number of shared co-authors 3

Collaborators

Pierre-Yves Bochud
Lausanne University Hospital
Co-authored papers 33
Zolt??n Kutalik
University of Lausanne
Co-authored papers 11
Laurent Kaiser
Geneva University Hospital
Co-authored papers 5
Matthias Cavassini
Lausanne University Hospital, University of Lausanne
Co-authored papers 3
Carlo Rivolta
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Co-authored papers 2
Bart L Haagmans
Erasmus Medical Center
Co-authored papers 2
Gladys Martinetti
Co-authored papers 2
Mathieu Quinodoz
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Co-authored papers 2
Szymon Pula
Co-authored papers 1
Paul J Tung
David Geffen School of Medicine, University of California-Los Angeles
Co-authored papers 1
Mathieu Bourgey
McGill University
Co-authored papers 1
Albandari Binowayn
King Fahad Medical City and King Abdulaziz City for Science and Technology
Co-authored papers 1
Nattiya Hirankarn
Chulalongkorn University
Co-authored papers 1
Ho Namkoong
Keio University School of Medicine
Co-authored papers 1
Daniel M Jordan
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Noam D Beckmann
Icahn School of Medicine at Mount Sinai.
Co-authored papers 1
Antonio Salas
Instituto de Investigacion Sanitaria de Santiago
Co-authored papers 1
Timothy Sanders
David Geffen School of Medicine, University of California-Los Angeles
Co-authored papers 1
Nicole Simons
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Efren Sandoval
Co-authored papers 1
Monnat Pongpanich
Chulalongkorn University
Co-authored papers 1
Joseph D Buxbaum
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Francisco Tanudjaja
Co-authored papers 1
Mateusz Sypniewski
MNM Bioscience Inc.
Co-authored papers 1
Yanara Marincevic-Zuniga
Uppsala University
Co-authored papers 1
Alexandre Bolze
The Rockefeller University
Co-authored papers 1
Shaun Dabe
Co-authored papers 1
Ebtehal A Alsolm
King Fahad Medical City and King Abdulaziz City for Science and Technology
Co-authored papers 1
Tatsuhiko Naito
Osaka University Graduate School of Medicine
Co-authored papers 1
Olaf Riess
Institute of Medical Genetics and Applied Genomics, University of Tuebingen
Co-authored papers 1
Release 1.2